Skip to main content

Thank you for visiting You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Letter
  • Published:

Mutations in the laminin α2–chain gene (LAMA2) cause merosin–deficient congenital muscular dystrophy


Congenital muscular dystrophies (CMDs), are heterogeneous autosomal recessive disorders. Their severe manifestations consist of early hypotonia and weakness, markedly delayed motor milestones and contractures, often associated with joint deformities1. Histological changes seen in muscle biopsies consist of large variations in muscle fibre size, a few necrotic and regenerating fibres and a marked increase in endomysial collagen tissue. Diagnosis is based on clinical features and on morphological changes. In several CMD cases, we have demonstrated an absence of one of the components of the extracellular matrix around muscle fibres, the merosin M chain2, now referred to as the α2 chain of laminin-2 (ref. 3). We localized this CMD locus to chromosome 6q2 by homozygosity mapping and linkage analysis4. The laminin α2 chain gene (LAMA2) maps to the same region on chromosome 6q22-23 (ref. 5). We therefore investigated LAMA2 for the presence of disease-causing mutations in laminin α2 chain-deficient CMD families and now report splice site and nonsense mutations in two families leading presumably to a truncated laminin α2 protein.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others


  1. Banker, B.Q. in Myology (eds Engel, A.G. & Franzini-Amstrong, C.) 1275–1289 (McGraw-Hill Book Company, New York, 1994).

    Google Scholar 

  2. Tomé, F.M.S. et al. Congenital muscular dystrophy with merosin deficiency. C. R. Acad. Sci. Paris 317, 351–357 (1994).

    PubMed  Google Scholar 

  3. Burgeson, R.E. et al. A new nomenclature for the laminins. Matrix Biol. 14, 209–211 (1994).

    Article  CAS  Google Scholar 

  4. Hillaire, D. et al. Localization of merosin-negative congenital muscular dystrophy to chromosome 6q2 by homozygosity mapping. Hum. molec. Genet. 3, 1657–1661 (1994).

    Article  CAS  Google Scholar 

  5. Vuolteenaho, R. et al. Human laminin M chain (merosin): complete primary structure, chromosomal assignment, and expression of the M and A chain in human fetal tissues. J. Cell Biol. 124, 381–394 (1994).

    Article  CAS  Google Scholar 

  6. Chelly, J., Concordet, J.P., Kaplan, J.C. & Kahn, A. Illegitimate transcription: transcription of any gene in any cell type. Proc. natn. Acad. Sci. U.S.A. 86, 2617–2621 (1989).

    Article  CAS  Google Scholar 

  7. Gee, S.H. et al. Laminin-binding protein 120 from brain is closely related to dystrophin-associated glycoprotein, dystroglycan, and binds with high affinity to the major heparin domain of laminin. J. biol. Chem. 268, 14972–14980 (1993).

    CAS  PubMed  Google Scholar 

  8. Sunada, Y., Bernier, S.M., Kosak, C.A., Yamada, Y. & Campbell, K.P. Deficiency of merosin in dystrophic dy mice and genetic linkage of the laminin M chain gene to the dy locus. J. biol. Chem. 269, 13759–13732 (1994).

    Google Scholar 

  9. Ervasti, J.M. & Campbell, K.P. Membrane organization of the dystrophin-glycoprotein complex. Cell 66, 1121–1131 (1991).

    Article  CAS  Google Scholar 

  10. Campbell, K.P. Three muscular dystrophies: loss of cytoskeleton-extracellular matrix linkage. Cell 80, 675–679 (1995).

    Article  CAS  Google Scholar 

  11. Xu, H., Wu, X-R., Werner, U.M. & Engvall, E. Murine muscular dystrophy caused by a mutation in the laminin α2 (Lama 2) gene. Nature Genet. 8, 297–302 (1995).

    Article  Google Scholar 

  12. Arahata, K. et al. Laminin in animal models for muscular dystrophy. Defect of laminin M in skeletal and cardiac muscles and peripheral nerve of the homozygous dystrophic dy/dy mice. Proc. Japan Acad. 69, 259–264 (1993).

    Article  Google Scholar 

  13. Dubowitz, V. 22nd ENMC sponsored workshop on congenital muscular dystrophy held in Baarn, The Netherlands, 14–16 May 1993. Neuromusc. Disord. 4, 75–81 (1994).

    Article  CAS  Google Scholar 

  14. Leivo, I. & Engvall, E. Merosin, a protein specific for basement membranes of Schwann cells, striated muscle, and trophoblast, is expressed late in nerve and muscle development. Proc. natn. Acad. Sci. U.S.A. 85, 1544–1548 (1988).

    Article  CAS  Google Scholar 

  15. Engvall, E., Earwicker, D., Haaparanta, T., Ruoslahti, E. & Sanes, J.R. Distribution and isolation of four laminin variants; tissue restricted distribution of heterotrimers assembled from five different subunits. Cell Regul. 1, 731–740 (1990).

    Article  CAS  Google Scholar 

  16. Chirgwin, J.M., Przybyla, A.E., MacDonald, R.J. & Rutter, W.J. Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry 18, 5294–5299 (1979).

    Article  CAS  Google Scholar 

  17. Don, R.H., Cox, P.T., Wainwright, B.J., Baker, K. & Mattick, J.S. “Touchdown” PCR to circumvent spurious priming during gene amplification. Nucl. Acids Res. 19, 4008 (1991).

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations


Rights and permissions

Reprints and permissions

About this article

Cite this article

Helbling-Leclerc, A., Zhang, X., Topaloglu, H. et al. Mutations in the laminin α2–chain gene (LAMA2) cause merosin–deficient congenital muscular dystrophy. Nat Genet 11, 216–218 (1995).

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI:

This article is cited by


Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing